Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00353535
Status:
COMPLETED
Last Update Posted:
2006-07-18
First Post:
2006-07-17
Brief Title:
Total Lymphoid Irradiation TLI to Prevent Focal Segmental Glomerulosclerosis FSGSRecurrence in the Renal Graft
Sponsor:
University of Sao Paulo
Organization:
University of Sao Paulo
Study Overview
Official Title:
Phase 1 Study of TLI Pretransplant to Prevent Recurrence of FSGS in the Graft
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose was study the immunosuppression using total lymphoid irradiation plus Csa MMF and prednisone pretransplant to prevent focal segmental glomerulosclerosis recurrence in the renal graft
Detailed Description:
Focal and segmental glomerulosclerosis FSGS is resistant to treatment with immunosuppressants and after transplant 40 of such patients have recurrences in renal allograft The purpose of this trial was to use Total Lymphoid Irradiation TLI plus mycophenolate mofetil MMF cyclosporine A CsA and prednisone PRED to prevent recurrence
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None